Study title:
Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488)
- Publication in the dos. Allemand jan 1981 -Cytosine arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia - Yates, J. W., Wallace, H. J., Ellison, R. R., Holland, J. F. - 1973 (Cancer Chemotherapy Rep. Part 1 Vol. 57 No. 4, 485 - 488)
- Publication in the dos. Allemand jan 1981 -
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: DAUNORUBICIN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|